Back
PTC Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
PTCT
Sponsored
32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PTCT
PTC Therapeutics
Last Price:
50.29
Seasonality Move:
17.12%
7 Day Trial
ALL ACCESS PASS
$
7
Time-Waster to Money-Maker: Join Mode Mobile's $1T Revolution
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.PTC Therapeutics Price Quote
$50.29
-1.78 (-3.42%)
(Updated: December 3, 2024 at 5:55 PM ET)
PTC Therapeutics Key Stats
Buy
51
PTC Therapeutics (PTCT)
is a Buy
Day range:
$49.28 - $54.16
52-week range:
$23.58 - $52.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.42
P/B ratio:
0%
Volume:
3.5M
Avg. volume:
844.1K
1-year change:
117.05%
Market cap:
$4B
Revenue:
$937.8M
EPS:
$-5.94
How Much Does PTC Therapeutics Make?
-
How Much Are PTC Therapeutics's Sales Annually?
PTCT Revenues are $937.8M -
How Much Profit Does PTC Therapeutics's Make A Year?
PTCT net income is -$626.6M
Is PTC Therapeutics Growing As A Company?
-
What Is PTC Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0% -
What Is PTC Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
PTC Therapeutics Stock Price Performance
-
Did PTC Therapeutics Stock Go Up Last Month?
PTC Therapeutics share price went up by 28.66% last month -
Did PTCT's Share Price Rise Over The Last Year?
PTCT share price rose by 117.05% over the past 1 year
What Is PTC Therapeutics 52-Week High & Low?
-
What Is PTC Therapeutics’s 52-Week High Share Price?
PTC Therapeutics has traded as high as $52.97 over the past 52 weeks -
What Is PTC Therapeutics’s 52-Week Low Share Price?
PTC Therapeutics has traded as low as $23.58 over the past 52 weeks
PTC Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy PTC Therapeutics?
-
How Much Debt Does PTC Therapeutics Have?
Total long term debt quarterly is $285.1M -
How Much Cash Does PTC Therapeutics Have?
Cash and short term investments quarterly total is $1B -
What Is PTC Therapeutics’s Book Value Per Share?
Book value per share is -13.70
Is PTC Therapeutics Cash Flow Positive?
-
What Is PTCT Cash Flow From Operations?
Cash flow from operations (TTM) is -$178M -
What Is PTC Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $849.9M -
What Is PTC Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$317.9M
PTC Therapeutics Return On Invested Capital
Data Unavailable
PTC Therapeutics Earnings Date & Stock Price
-
What Is PTC Therapeutics's Stock Price Today?
A single share of PTCT can be purchased today for 52.07 -
What Is PTC Therapeutics’s Stock Symbol?
PTC Therapeutics trades on the nasdaq under the ticker symbol: PTCT -
When Is PTC Therapeutics’s Next Earnings Date?
The next quarterly earnings date for PTC Therapeutics is scheduled on February 28, 2025 -
When Is PTCT's next ex-dividend date?
PTC Therapeutics's next ex-dividend date is December 4, 2024 -
How To Buy PTC Therapeutics Stock?
You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
PTC Therapeutics Competitors
-
Who Are PTC Therapeutics's Competitors?
Below is a list of companies who compete with PTC Therapeutics or are related in some way:
PTC Therapeutics Dividend Yield
-
What Is PTCT Dividend Yield?
PTC Therapeutics’s dividend yield currently is 0% -
What Is PTC Therapeutics’s Payout Ratio?
PTC Therapeutics’s payout ratio is 0% -
When Did PTC Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 4, 2024 -
What Is PTC Therapeutics’s Dividend Per Share?
PTC Therapeutics pays a dividend of $0.00 per share
PTC Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 17.76% |
Revenue: | 0.11% | 14.54% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 1 |
Price Target: | 48.43 |
Downside from Last Price: | -6.99% |